Bicuspid aortic valve (BAV) is a common congenital heart defect where the aortic valve has two leaflets (cusps) instead of the usual three, resulting in abnormal blood flow and development of aortic ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace your aortic valve. The aortic valve controls blood flow from your heart to your aorta, the main artery that ...

The aortic valve sits between the heart’s left ventricle and the aorta. It opens and closes with the heartbeat to allow blood to flow to the body without leaking back into the heart. It may need to be ...

There are three types of bicuspid aortic valves — types 0, 1, and 2. Experts classify these types based on whether the leaflets of the valve have fused to form a ridge. A bicuspid aortic valve is a ...

A bicuspid aortic valve may present few problems throughout your life. But you’ll still need to live a heart-healthy lifestyle and monitor your cardiovascular system to prevent complications. The ...

An aortic valve calcium score (AVCS) greater than 4510 arbitrary units independently predicts post–transcatheter aortic valve implantation (TAVI) conductive disorders requiring permanent pacemaker ...

Transcatheter aortic valve implantation (TAVI) has been touted for “revolutionizing the field of cardiology,” as the preferred treatment for most patients over age 70 years with severe aortic stenosis ...

You may not need surgery to repair an aortic valve. A nonsurgical catheter procedure with small incisions may be a better option in some cases. Share on Pinterest Getty Images When the aortic valve in ...

Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following prior transcatheter aortic valve replacement (TAVR), a clinical scenario ...

Your aortic valve is part of your heart, a strong muscle that pumps blood through your body. The aortic valve controls the blood flowing out from the heart. It opens every time your heart contracts, ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter ...

PHOENIX, AZ—Patients who require cardiac surgery on another valve after initially being treated with TAVI have very high operative morbidity and mortality, with a 30-day death rate exceeding 17%, ...